143 related articles for article (PubMed ID: 9861275)
1. Onchocerciasis: the burden of disease.
Kale OO
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S101-15. PubMed ID: 9861275
[TBL] [Abstract][Full Text] [Related]
2. Eye lesions, blindness and visual impairment in the Taraba river valley, Nigeria and their relation to onchocercal microfilariae in skin.
Akogun OB
Acta Trop; 1992 Jun; 51(2):143-9. PubMed ID: 1354932
[TBL] [Abstract][Full Text] [Related]
3. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
[TBL] [Abstract][Full Text] [Related]
4. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa.
Murdoch ME; Asuzu MC; Hagan M; Makunde WH; Ngoumou P; Ogbuagu KF; Okello D; Ozoh G; Remme J
Ann Trop Med Parasitol; 2002 Apr; 96(3):283-96. PubMed ID: 12061975
[TBL] [Abstract][Full Text] [Related]
5. The burden of Onchocerca volvulus in Sudan.
Mukhtar MM; Khier MM; Baraka OZ; Homeida MM
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S129-31. PubMed ID: 9861278
[TBL] [Abstract][Full Text] [Related]
6. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
7. Onchocercal eye disease and the impact of Mectizan treatment.
Abiose A
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis in Ecuador: ocular findings in Onchocerca volvulus infected individuals.
Cooper PJ; Proaño R; Beltran C; Anselmi M; Guderian RH
Br J Ophthalmol; 1995 Feb; 79(2):157-62. PubMed ID: 7696237
[TBL] [Abstract][Full Text] [Related]
9. Studies on filariasis in Bauchi State, Nigeria. 1. Endemicity of human onchocerciasis in Ningi Local Government Area.
Anosike JC; Onwuliri CO
Ann Trop Med Parasitol; 1995 Feb; 89(1):31-8. PubMed ID: 7741592
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
[TBL] [Abstract][Full Text] [Related]
11. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
[TBL] [Abstract][Full Text] [Related]
12. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
13. A study of onchocerciasis with severe skin and eye lesions in a hyperendemic zone in the forest of southwestern Cameroon: clinical, parasitologic, and entomologic findings.
Somo RM; Enyong PA; Fobi G; Dinga JS; Lafleur C; Agnamey P; Ngosso A; Ngolle EM
Am J Trop Med Hyg; 1993 Jan; 48(1):14-9. PubMed ID: 8427383
[TBL] [Abstract][Full Text] [Related]
14. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
[TBL] [Abstract][Full Text] [Related]
15. The burden of onchocerciasis in Uganda.
Ndyomugyenyi R
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S133-7. PubMed ID: 9861279
[TBL] [Abstract][Full Text] [Related]
16. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch ME; Murdoch IE; Evans J; Yahaya H; Njepuome N; Cousens S; Jones BR; Abiose A
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005489. PubMed ID: 28355223
[TBL] [Abstract][Full Text] [Related]
17. [Onchocerciasis].
Enk CD; Gardlo K; Ruzicka T; BenEzra D
Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
[TBL] [Abstract][Full Text] [Related]
18. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
19. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda.
Kipp W; Bamhuhiiga J
Am J Trop Med Hyg; 2002 Nov; 67(5):475-9. PubMed ID: 12479547
[TBL] [Abstract][Full Text] [Related]
20. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
